{"id":13770,"date":"2022-08-03T13:42:06","date_gmt":"2022-08-03T13:42:06","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?p=13770"},"modified":"2022-08-03T13:42:06","modified_gmt":"2022-08-03T13:42:06","slug":"oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/","title":{"rendered":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale"},"content":{"rendered":"

Lupta \u00eempotriva cancerului, at\u00e2t la nivel european, c\u00e2t \u0219i na\u021bional, beneficiaz\u0103 de instrumente financiare f\u0103r\u0103 precedent. Cele trei instrumente europene (Planul European de Combatere a Cancerului, Misiunea pentru Cancer din cadrul Orizont Europa \u0219i programul EU4Health) finan\u021beaz\u0103 \u00een mod direct ac\u021biunile \u00een oncologie. La nivel na\u021bional vor exista sume importante de bani alocate oncologiei prin Programul Na\u021bional de Redresare \u0219i Rezilien\u021b\u0103 (PNRR) \u0219i prin Programul Opera\u021bional S\u0103n\u0103tate (POS), gestionat de Ministerul Investi\u021biilor \u0219i Proiectelor Europene (MIPE). <\/strong><\/p>\n

Unit\u0103\u021bile medicale (at\u00e2t cele oncologice, c\u00e2t \u0219i spitalele jude\u021bene) vor putea accesa fonduri semnificative prin intermediul proiectelor depuse, au explicat participan\u021bii la dezbaterea \u201eOportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie\u201d, organizat\u0103, \u00een cadrul proiectului \u201e\u00cempreun\u0103 \u00cenvingem Cancerul\u201d, de revista Politici de S\u0103n\u0103tate cu sprijinul Asocia\u021biei Rom\u00e2ne a Produc\u0103torilor Interna\u021bionali de Medicamente (ARPIM). La eveniment au participat medici speciali\u0219ti \u00een oncologie medical\u0103 \u0219i hematologie, manageri \u0219i directori medicali ai institutelor de oncologie \u0219i ai spitalelor jude\u021bene, precum \u0219i reprezentan\u021bi ai consiliilor jude\u021bene, poten\u021biali beneficiari.<\/strong><\/p>\n

Instrumente europene de finan\u021bare<\/u><\/strong><\/p>\n

Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer, dar \u0219i prin Europa Digital\u0103, Instrumentul Euratom sau instrumentul de finan\u021bare interregional\u0103 a investi\u021biilor \u00een inovare (Interregional Innovation Investments funding instrument).<\/p>\n

Potrivit europarlamentarului Cristian Bu\u0219oi, pre\u0219edinte al Comisiei pentru Industrie, cercetare \u0219i energie (ITRE) \u0219i al Intergrupului de lupt\u0103 \u00eempotriva cancerului, \u00een momentul de fa\u021b\u0103 exist\u0103 cinci linii de finan\u021bare deschise cu termen final pe 7 septembrie.<\/p>\n

\u201dHORIZON-MISS-2022-CANCER-01-03 (Pragmatic clinical trials to optimise treatments for patients with refractory cancers<\/a>) este o cercetare focusat\u0103 pe alegerea pragmatic\u0103 a studiilor clinice \u00een tratarea pacien\u021bilor cu orice tip de cancer refractar, la orice v\u00e2rsta \u0219i \u00een orice stadiu.\u00a0 HORIZON-MISS-2022-CANCER-01-04 (Towards the creation of a European Cancer Patient Digital Centre<\/a>) are ca scop crearea Platformei digitale a unui Centru european digital pentru cancer la care s\u0103 aib\u0103 acces at\u00e2t pacien\u021bii, c\u00e2t \u0219i cercet\u0103torii \u0219i medicii. HORIZON-MISS-2022-CANCER-01-02 (Strengthening research capacities of Comprehensive Cancer Infrastructures<\/a>) este o cercetare referitoare la infrastructuri existente sau necesare, na\u021bionale sau regionale care ofer\u0103 resurse \u0219i servicii pentru a sprijini, a \u00eembun\u0103t\u0103\u021bi \u0219i a integra \u00eengrijirea cancerului, cercetarea, formarea profesioni\u0219tilor din domeniul \u00eengrijirii \u0219i educa\u021bia pentru pacien\u021bii cu cancer, supravie\u021buitorii \u0219i familiile\/\u00eengrijitorii. Prin linia de finan\u021bare HORIZON-MISS-2022-CANCER-01-05 (Establishing of national cancer mission hubs and creation of network to support the Mission on Cancer<\/a>), \u00een fiecare stat membru \u0219i \u00een fiecare \u021bar\u0103 asociat\u0103 va fi \u00eenfiin\u021bat un hub na\u021bional al misiunii pentru cancer care va functiona pe toata durata Misiunii, cu o prim\u0103 faz\u0103 de implementare de trei ani. Cea de- a 5-a linie – HORIZON-MISS-2022-CANCER-01-01 (Improving and upscaling primary prevention of cancer through implementation research<\/a>) va finan\u021ba cercet\u0103ri care vor identifica \u0219i aborda barierele ce \u00eempiedic\u0103 adoptarea \u0219i implementarea programelor de preven\u021bie efectiv\u0103. De asemenea, programele de prevenire primar\u0103 a cancerului ar trebui adaptate nevoilor particulare ale popula\u021biilor \u021bint\u0103, \u021bin\u00e2nd cont de condi\u021biile socio-economice, culturale \u0219i geografice. Instrumentele digitale \u0219i seturile de date pot fi parte integrant\u0103 a proiectului\u201d<\/em>, a explicat europarlamentarul rom\u00e2n.<\/p>\n

Programul de s\u0103n\u0103tate EU4Health poate finan\u021ba ac\u021biuni ce implementeaz\u0103 politici europene existente sau ac\u021biuni ce preg\u0103tesc, \u00eempreun\u0103 cu statele membre, lansarea de noi ini\u021biative. EU4Health include \u0219i sprijinirea ac\u021biunilor de \u00eembun\u0103t\u0103\u021bire a supravegherii, diagnostic\u0103rii \u0219i tratamentului bolilor transmisibile \u0219i netransmisibile, \u00een special a cancerului \u0219i a cancerului pediatric. Programul permite finan\u021barea de ac\u021biuni specifice \u00een lupta \u00eempotriva cancerului, mai ales a ac\u021biunilor incluse \u00een Planul european de combatere a cancerului lansat \u00een 2021, dar \u0219i a unor ac\u021biuni propuse de statele membre, conform celor agreate \u00een regulamentul UE pentru S\u0103n\u0103tate. Bugetul EU4Health pentru perioada 2021-2027 este de 5,3 miliarde de euro, iar programul de lucru 2022 are alocate 835,3 milioane de euro (din care 17,6% pentru cancer). Detaliile programului de lucru 2022- AICI<\/a>.<\/p>\n

Toate apelurile pentru programul Eu4Health\u00a0 2021 au fost publicate. Dintre cele relevante pentru lupta \u00eempotriva cancerului, vor fi deschise \u00een toamna acestui an dou\u0103 apeluri competitive sub programul anual 2022. Unul este destinat ac\u021biunilor pentru prevenirea cancerului \u0219i altor boli netransmisibile, cu un buget de 11 milioane euro, iar altul este pentru finan\u021barea etapei a doua a programului de instruire \u00eentre specialit\u0103\u021bi, cu un buget de 7 milioane euro.<\/p>\n

Parteneriat public- privat<\/u><\/strong><\/p>\n

INNOVATIVE HEALTH INITIATIVE (IHI) este o ini\u021biativ\u0103 european\u0103 focalizat\u0103 pe proiecte de cercetare, cancerul ocup\u00e2nd o parte important\u0103. Este cel mai mare parteneriat public-privat \u00eentre Uniunea European\u0103, reprezentat\u0103 de Comisia European\u0103, \u0219i industriile farmaceutic\u0103 \u0219i de biotehnologii inovatoare \u0219i, de asemenea, este continuatorul programului Innovative Medicines Initiative. Partenerii sunt\u00a0 COCIR – asocia\u021bie interna\u021bional\u0103 focalizat\u0103 pe imagistic\u0103 \u0219i radioterapie, EFPIA (inclusiv Vaccines Europe), EuropaBio, MedTech, specializate pe biotehnologie \u0219i echipamente medicale. \u201ePentru perioada 2021-2027,\u00a0 aceast\u0103 ini\u021biativ\u0103 are un buget de 2,4 miliarde de euro repartizate astfel: o finan\u021bare de 1,3 miliarde de euro din partea Comisiei Europene prin programul Orizont Europa, un miliard de la partenerii mari din industria farmaceutic\u0103 \u0219i 200 milioane de euro de la al\u021bi parteneri. \u00cen r\u00e2ndul membrilor desemna\u021bi de statele membre IHI, Rom\u00e2nia este reprezentat\u0103 de dr. \u0218tefan Busnatu, consilier al ministrului S\u0103n\u0103t\u0103\u021bii \u0219i prodecan al Facult\u0103\u021bii de Medicin\u0103 din cadrul Universit\u0103\u021bii de Medicin\u0103 \u0219i Farmacie Carol Davila Bucure\u0219ti\u201d,<\/em> a afirmat dr. Ioana Bianchi, director Rela\u021bii Externe \u00een cadrul ARPIM.<\/p>\n

Dintre proiectele \u00een curs, care au fost lansate pe data de 28 iunie 2022 \u0219i au termen limit\u0103 de depunere 20 septembrie a.c, dou\u0103 se refer\u0103 strict la cancer (imagistic\u0103, tratament<\/a> \u0219i oncologie personalizat\u0103<\/a>) \u0219i dispun de o finan\u021bare total\u0103 de 80 milioane euro.<\/p>\n

POS – depus \u00een varianta final\u0103 la Comisia European\u0103<\/u><\/strong><\/p>\n

Programul Opera\u021bional de S\u0103n\u0103tate (POS) a fost deja depus la Comisia European\u0103. Programul este aliniat ini\u021biativelor europene de elaborare a Planului European de Combatere a Cancerului \u0219i \u00eencorporeaz\u0103 acum, pe domeniile pe care le finan\u021beaz\u0103,\u00a0 \u00eentreg lan\u021bul de servicii, de la m\u0103suri de preven\u021bie, diagnostic \u0219i tratament p\u00e2n\u0103 la partea de palia\u021bie. O prioritate, dar \u0219i o condi\u021bie obligatorie a POS, a reprezentat-o integrarea serviciilor medicale, astfel \u00eenc\u00e2t pacien\u021bii s\u0103 beneficieze de un parcurs continuu, nefragmentat, pe toat\u0103 durata procesului medical.<\/p>\n

\u201ePentru diagnostic \u0219i tratament, Programul va aloca sume considerabile pentru investi\u021biile \u00een infrastructur\u0103 \u0219i dot\u0103ri, dar \u0219i m\u0103suri de tip FSE+. \u00cen prioritatea 1 avem investi\u021bii \u00een infrastructura public\u0103 a unit\u0103\u021bilor sanitare, dar doar a celor care desf\u0103\u0219oar\u0103 activit\u0103\u021bi medicale de tip ambulatoriu. Aici vor fi unit\u0103\u021bile sanitare care vor implementa programul de screening popula\u021bional. Va exista o alocare substan\u021bial\u0103, de aproximativ 200 milioane de euro (alocare de tip apel de proiecte cu o competi\u021bie \u00eentre poten\u021bialii beneficiari). La prioritatea 2 sunt finan\u021b\u0103ri pentru domeniul de palia\u021bie \u2013\u00a0 masterplanurile regionale de servicii medicale ar trebui s\u0103 eviden\u021bieze exact jude\u021bele unde nu exist\u0103 un astfel de centru, iar Programul de S\u0103n\u0103tate trebuie s\u0103 direc\u021bioneze finan\u021barea cu prec\u0103dere c\u0103tre acestea. Finan\u021barea este de aproximativ 40-50 milioane de euro. \u00cen prioritatea 3, pe partea de FEDR, sunt prev\u0103zute investi\u021bii \u00een centrele regionale de genetic\u0103 \u0219i \u00een laboratoarele de anatomie patologic\u0103. Pe partea de m\u0103suri soft FSE+ vor continua programele de screening popula\u021bional, finan\u021bate p\u00e2n\u0103 acum la nivel de proiecte-pilot prin Programul Opera\u021bional Capital Uman (programul de screening pentru cancer de col uterin, cancer mamar \u0219i cancer colorectal\u201d,<\/em> a explicat Dan Dumitrescu<\/strong>, secretar de stat \u00een Ministerul Investi\u021biilor \u0219i Proiectelor Europene.<\/p>\n

PNRR \u2013 2,5 miliarde de euro pentru resurse umane, infrastructur\u0103 \u0219i \u00eembun\u0103t\u0103\u021birea serviciilor medicale<\/strong><\/p>\n

Datele ne arat\u0103 c\u0103 aproximativ 40% din cancere pot fi prevenite, iar \u00een acest sens este esen\u021bial screeningul \u0219i accesul la un diagnostic precoce. \u201ePentru acestea e nevoie de o infrastructur\u0103 \u00een care s\u0103 se desf\u0103\u0219oare toate aceste ample ac\u021biuni. Tocmai aici ne va ajuta PNRR, care va veni cu o important\u0103 contribu\u021bie la dezvoltarea infrastructurii, at\u00e2t spitalice\u0219ti, c\u00e2t \u0219i la nivel de medicin\u0103 primar\u0103. Vor exista investi\u021bii importante \u00een sectorul prespitalicesc \u2013 vom avea posibilitatea de a dota peste 3000 de cabinete de medicin\u0103 de familie. Exist\u0103 \u0219i numeroase ac\u021biuni legate de screening, caravane mobile, centre comunitare, toate acestea cre\u00e2nd condi\u021biile necesare pentru a implementa ample activit\u0103\u021bi de\u00a0 prevenire \u0219i diagnostic precoce a c\u00e2t mai multor cancere\u201d<\/em>, a afirmat dr. Andrei Baciu, secretar de stat \u00een Ministerul S\u0103n\u0103t\u0103\u021bii.<\/p>\n

\u00cen fiecare jalon al Programului Na\u021bional de Redresare \u0219i Rezilien\u021b\u0103 (PNRR) exist\u0103 obiective de investi\u021bii dedicate, \u00eentr-o oarecare m\u0103sur\u0103, \u0219i pacien\u021bilor oncologici. PNRR este un program complex, care \u00ee\u0219i propune s\u0103 ating\u0103 at\u00e2t segmentul resurselor umane, cel al mecanismelor de finan\u021bare, a serviciilor de s\u0103n\u0103tate, c\u00e2t \u0219i segmentul investi\u021biilor \u00een infrastructura de s\u0103n\u0103tate \u0219i dotarea cu echipamente a segmentelor prespitalice\u0219ti \u0219i spitalice\u0219ti, \u00een valoare total\u0103 de aproximativ 2,5 miliarde de euro.<\/p>\n

\u201ePNRR este structurat \u00een dou\u0103 mari componente: Reforme \u0219i Investi\u021bii. Capitolul de reforme este compus din Reforma I, care se refer\u0103 la dezvoltarea capacit\u0103\u021bii pentru gestionarea fondurilor publice din s\u0103n\u0103tate, noi mecanisme de plat\u0103 a serviciilor etc. Reforma II \u00ee\u0219i propune dezvoltarea unei noi agen\u021bii pentru infrastructura de s\u0103n\u0103tate (ANDIS), care va monitoriza \u0219i va implementa spitalele regionale \u00een prima faz\u0103 \u0219i, ulterior, alte zone de infrastructur\u0103 sanitar\u0103. Reforma III are ca obiectiv dezvoltarea capacit\u0103\u021bii pentru managementul serviciilor de s\u0103n\u0103tate \u0219i managementul resurselor umane din s\u0103n\u0103tate. Investi\u021biile \u00een s\u0103n\u0103tate cuprind at\u00e2t zona prespitaliceasc\u0103, unde discut\u0103m despre cabinetele medicilor de familie, ambulatorii, centre comunitare integrate, caravane mobile de screening \u0219i cabinete de planning familial, c\u00e2t \u0219i \u00een zona spitaliceasc\u0103, unde principalele obiective de investi\u021bii sunt \u00een construirea de noi unit\u0103\u021bi publice spitalice\u0219ti \u0219i dotarea cu echipamente medicale de \u00eenalt\u0103 performan\u021b\u0103, dezvoltarea \u0219i extinderea compartimentelor \u0219i a sec\u021biilor de terapie intensiv\u0103 neonatal\u0103 \u0219i dotarea cu echipamente specifice a unit\u0103\u021bilor publice spitalice\u0219ti \u00een vederea reducerii infec\u021biilor nosocomiale<\/em>\u201d, potrivit asist. univ. dr. Alexandru Rogobete<\/strong>, consilier al ministrului S\u0103n\u0103t\u0103\u021bii.<\/p>\n

Prin reforma managementului serviciilor de s\u0103n\u0103tate (cu un buget disponibil de peste 25 milioane de euro) se dore\u0219te o \u00eembun\u0103t\u0103\u021bire a dezvolt\u0103rii personalului din managementul spitalelor \u0219i nu numai, crearea unor parcursuri profesionale clare, modific\u0103ri legislative \u00een ceea ce prive\u0219te perfec\u021bionarea continu\u0103 a managementului \u00een serviciile de s\u0103n\u0103tate. Dezvoltarea resurselor umane din s\u0103n\u0103tate (cu un buget de aproape 54 milioane de euro) este focusat\u0103 at\u00e2t pe personalul existent, c\u00e2t \u0219i pe cel viitor. \u00cen ceea ce prive\u0219te investi\u021biile \u00een dezvoltarea infrastructurii spitalice\u0219ti publice, acestea se ridic\u0103 la aproape 2,27 miliarde de euro.<\/p>\n

De la infrastructur\u0103 la acreditare interna\u021bional\u0103 <\/strong><\/p>\n

\u00cen domeniul oncologiei, Universitatea de Medicin\u0103 \u0219i Farmacie \u201eVictor Babe\u0219\u201d din Timi\u0219oara a demarat, \u00eempreun\u0103 cu Societatea German\u0103 de Cancer, un proiect prin care se standardizeaz\u0103 circuitul pacientului, modul \u00een care este el \u00eengrijit, modul \u00een care colaboreaz\u0103 multiplele specialit\u0103\u021bi implicate \u00een acest act medical at\u00e2t de complex.<\/p>\n

\u201eSocietatea German\u0103 de Cancer a dezvoltat acest proces de standardizare a \u00eengrijirilor pornind, desigur, de la standardizarea aspectului medical, tehnic, al \u00eengrijirii pacien\u021bilor prin elaborarea de ghiduri, dar \u0219i a indicatorilor de calitate a \u00eengrijirilor din diverse centre oncologice. Aceste obiective finale au fost realizate prin certificarea centrelor oncologice. Acest proces de certificare \u00eenseamn\u0103 mai multe etape, av\u00e2nd ca obiective realizarea re\u021belei de speciali\u0219ti, de specializ\u0103ri calificate, \u0219i a modului de comunicare interdisciplinar\u0103 \u00eentre institu\u021bii care s\u0103 acopere \u00eentregul lan\u021b de \u00eengrijire pentru pacientul oncologic. Societatea german\u0103 de oncologie are \u00een eviden\u021b\u0103 peste 140 de centre oncologice \u0219i 1122 de centre de cancer de organ. \u00cen fiecare an, peste 275.000 de pacien\u021bi cu un diagnostic primar de cancer sunt trata\u021bi. Centrele acreditate de Societatea german\u0103 de cancer sunt localizate \u00een \u0219ase \u021b\u0103ri \u0219i reprezint\u0103 cel mai bine implementat program pentru oncologie din Europa. Putem acum s\u0103 ne raliem la aceast\u0103 ini\u021biativ\u0103 pentru a \u00eenregistra un progres major \u00een organizare, \u00een rela\u021bionarea interspecialit\u0103\u021bi \u0219i, \u00een final, \u00een calitatea \u00eengrijirii pacien\u021bilor\u201d<\/em>, a\u00a0 anun\u021bat prof. dr. Dorel S\u0103ndesc<\/strong>, pre\u0219edintele Comisiei de anestezie \u0219i terapie intensiv\u0103 din Ministerul S\u0103n\u0103t\u0103\u021bii.<\/p>\n

Pentru informa\u021bii suplimentare:<\/p>\n

Valentina Grigore, Project Leader proiect \u201d\u00cempreun\u0103 \u00cenvingem Cancerul\u201d<\/p>\n

Tel. 0740.931.161<\/p>\n

e-mail: valentina.grigore@politicidesanatate.ro<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Lupta \u00eempotriva cancerului, at\u00e2t la nivel european, c\u00e2t \u0219i na\u021bional, beneficiaz\u0103 de instrumente financiare f\u0103r\u0103 precedent. Cele trei instrumente europene (Planul European de Combatere a Cancerului, Misiunea pentru Cancer din […]<\/p>\n","protected":false},"author":4,"featured_media":13771,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-13770","post","type-post","status-publish","format-standard","has-post-thumbnail","category-stiri-noutati"],"yoast_head":"\nOportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici<\/title>\n<meta name=\"description\" content=\"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici\" \/>\n<meta property=\"og:description\" content=\"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-03T13:42:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"236\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ralucab\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"ralucab\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\"},\"author\":{\"name\":\"ralucab\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"headline\":\"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale\",\"datePublished\":\"2022-08-03T13:42:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\"},\"wordCount\":2159,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg\",\"articleSection\":[\"Stiri \/ Noutati\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\",\"name\":\"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg\",\"datePublished\":\"2022-08-03T13:42:06+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\"},\"description\":\"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg\",\"width\":600,\"height\":236},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35\",\"name\":\"ralucab\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g\",\"caption\":\"ralucab\"},\"url\":\"https:\/\/jurmed.ro\/medici\/author\/ralucabocancia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici","description":"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/","og_locale":"ro_RO","og_type":"article","og_title":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici","og_description":"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer","og_url":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/","og_site_name":"Jurmed - Medici","article_published_time":"2022-08-03T13:42:06+00:00","og_image":[{"width":600,"height":236,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg","type":"image\/jpeg"}],"author":"ralucab","twitter_misc":{"Scris de":"ralucab","Timp estimat pentru citire":"9 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/"},"author":{"name":"ralucab","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"headline":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale","datePublished":"2022-08-03T13:42:06+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/"},"wordCount":2159,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg","articleSection":["Stiri \/ Noutati"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/","url":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/","name":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale - Jurmed - Medici","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg","datePublished":"2022-08-03T13:42:06+00:00","author":{"@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35"},"description":"investi\u021bii \u00een oncologie Cercetarea, inovarea, tehnologia \u0219i controlul cancerului sunt finan\u021bate prin programul Orizont Europa \u0219i Misiunea pentru Cancer","breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2022\/08\/investitii-in-oncologie.jpg","width":600,"height":236},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/oportunitati-de-finantare-pentru-investitii-in-oncologie-instrumente-europene-si-nationale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Oportunit\u0103\u021bi de finan\u021bare pentru investi\u021bii \u00een oncologie \u2013 instrumente europene \u0219i na\u021bionale"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/364b734872ee04688e0b7121c65eaa35","name":"ralucab","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/247da7eca7bcc01a299ead1f5ff5ecede6d54a6373d3f9437c1c12da13a216c6?s=96&r=g","caption":"ralucab"},"url":"https:\/\/jurmed.ro\/medici\/author\/ralucabocancia\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/comments?post=13770"}],"version-history":[{"count":1,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13770\/revisions"}],"predecessor-version":[{"id":13772,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/13770\/revisions\/13772"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/13771"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=13770"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/categories?post=13770"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=13770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}